US Patent 11286532 Estrogen receptor mutations and uses thereof

Patent 11286532 was granted and assigned to Foundation Medicine on March, 2022 by the United States Patent and Trademark Office.

Overview Structured Data Issues Contributors Activity

Is a

Patent

Patent attributes

Patent Applicant

Foundation Medicine

Current Assignee

Foundation Medicine

Patent Jurisdiction

United States Patent and Trademark Office

Patent Number

11286532

Date of Patent

March 29, 2022

Patent Application Number

15877035

Date Filed

January 22, 2018

Patent Citations Received

‌

US Patent 12116638 Estrogen receptor mutations and uses thereof

Patent Primary Examiner

CPC Code

Novel mutant ESR1 molecules and uses are disclosed.

Timeline

No Timeline data yet.

Further Resources

Title

Author

Link

Type

Date

No Further Resources data yet.

References

Find more entities like US Patent 11286532 Estrogen receptor mutations and uses thereof

Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.

Open Query Tool

Access by API